CompletedHealthcare10 July 2026

American Type Culture Collection, Inc. to acquire Lifeline Cell Technology, LLC

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

Deal facts

Buyer
American Type Culture Collection, Inc.
Target
Lifeline Cell Technology, LLC
Deal value
Not disclosed
Announced
10 July 2026
Status
Completed
Sector
Healthcare
Country
United States
Consideration
Not stated
What we know

American Type Culture Collection, Inc. has agreed to acquire Lifeline Cell Technology, LLC in a strategic acquisition within the healthcare sector. The transaction was announced on 10 July 2026 and completed on 1 September 2026. Both entities are based in the United States. The financial value of the deal was not disclosed, and no specific currency or consideration type was reported by the parties involved. This acquisition represents a consolidation within the US healthcare market, bringing together two organisations operating in related fields without public disclosure of the monetary terms or the specific strategic rationale behind the combination.

The deal structure is classified as a standard strategic acquisition rather than a management buyout, buy-in, or merger of equals. No other buyers or competitors were mentioned in the available data. The transaction has been finalised and is no longer pending regulatory review or shareholder approval. The completion date confirms that all necessary steps for the transfer of ownership have been executed. This summary provides the essential factual framework for understanding the scope and timing of the acquisition, focusing solely on the reported entities, dates, and sector classification without speculation on future performance or integration plans.

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

1 update
  1. CompletedClosed

    American Type Culture Collection, Inc. completes acquisition of Lifeline Cell Technology, LLC

    Item 2.01 Completion of Acquisition or Disposition of Assets. As previously disclosed, on July 10, 2026, International Stem Cell Corporation, a Delaware corporation (the “Company” or “Parent”), International Stem Cell Corporation, a California corporation (“Intermediate” and, together with Parent, “Seller”), Lifeline Cell Technology, LLC, a California limited liability company (“LCT”), and America

    Source

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

Similar deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

Buyer history

American Type Culture Collection, Inc.

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive